# Anixa Biosciences Inc: Form 8-K, filed Mar 11, 2026

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 8-K
- Filed: 2026-03-11
- Accepted by EDGAR: Mar 11, 2026, 17:03 ET
- Period: 2026-03-10
- Accession: 0001493152-26-009699
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315226009699/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315226009699/

## Items reported

- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315226009699/form8-k.htm

Filed Mar 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-009699. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.